Jade Biosciences, Inc.
JBIO
$13.97
-$0.28-1.97%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/17/2026
-
Tickeron - Stocks
3/17/2026
-
Tickeron - Stocks
3/17/2026
-
Tickeron - Stocks
3/16/2026
-
MarketBeat
3/16/2026
-
MarketBeat
3/12/2026
-
MarketBeat
3/12/2026
-
Tickeron - Stocks
3/11/2026
-
MarketBeat
3/11/2026
-
TipRanks Financial Blog
3/11/2026
-
Tickeron - Stocks
3/11/2026
-
Tickeron - Stocks
3/10/2026
-
Ticker Report
3/10/2026
-
MarketBeat
3/10/2026
-
Ticker Report
3/10/2026
-
Tickeron - Technical Analysis
Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Dyne Therapeutics (DYN)
3/9/2026
-
TipRanks Financial Blog
3/9/2026
-
MarketBeat
3/9/2026
-
TipRanks Financial Blog
3/8/2026
-
MarketBeat
3/7/2026
-
Ticker Report
3/7/2026
-
MarketBeat
3/6/2026
-
TipRanks Financial Blog
3/6/2026
-
The Fly
3/6/2026
-
Globe Newswire
3/5/2026
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, March 6, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
781 312 3013
Address
Building 23
Suite 105 - 221 Crescent Street
Waltham, MA 02453
Suite 105 - 221 Crescent Street
Waltham, MA 02453
Country
Year Founded
--
Business Description
Sector
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a...
more